The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hepatitis A Vaccine Market Research Report 2023

Global Hepatitis A Vaccine Market Research Report 2023

Publishing Date : Jan, 2023

License Type :
 

Report Code : 1411305

No of Pages : 93

Ask Your Query

Synopsis
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Highlights
The global Hepatitis A Vaccine market was valued at US$ 705.8 million in 2022 and is anticipated to reach US$ 840.5 million by 2029, witnessing a CAGR of 2.2% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%.
Asia-Pacific is the largest market, with a share over 35%, followed by North America and Europe , both have a share over 55 percent.
In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine.
The Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

  • Gsk
  • Merck
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute Of Biological
  • Km Biologics
  • Imbcams
  • Convac

Segment by Type

  • Inactivated Vaccine
  • Live Attenuated Vaccine

Segment by Application

  • Government Institution
  • Private Sector
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Hepatitis A Vaccine Market Overview
1.1 Product Overview and Scope of Hepatitis A Vaccine
1.2 Hepatitis A Vaccine Segment by Type
1.2.1 Global Hepatitis A Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine Segment by Application
1.3.1 Global Hepatitis A Vaccine Market Value by Application: (2023-2029)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A Vaccine Market Size Estimates and Forecasts
1.4.1 Global Hepatitis A Vaccine Revenue 2018-2029
1.4.2 Global Hepatitis A Vaccine Sales 2018-2029
1.4.3 Global Hepatitis A Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hepatitis A Vaccine Market Competition by Manufacturers
2.1 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hepatitis A Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Hepatitis A Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hepatitis A Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis A Vaccine, Product Type & Application
2.7 Hepatitis A Vaccine Market Competitive Situation and Trends
2.7.1 Hepatitis A Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatitis A Vaccine Players Market Share by Revenue
2.7.3 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis A Vaccine Retrospective Market Scenario by Region
3.1 Global Hepatitis A Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hepatitis A Vaccine Global Hepatitis A Vaccine Sales by Region: 2018-2029
3.2.1 Global Hepatitis A Vaccine Sales by Region: 2018-2023
3.2.2 Global Hepatitis A Vaccine Sales by Region: 2024-2029
3.3 Global Hepatitis A Vaccine Global Hepatitis A Vaccine Revenue by Region: 2018-2029
3.3.1 Global Hepatitis A Vaccine Revenue by Region: 2018-2023
3.3.2 Global Hepatitis A Vaccine Revenue by Region: 2024-2029
3.4 North America Hepatitis A Vaccine Market Facts & Figures by Country
3.4.1 North America Hepatitis A Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hepatitis A Vaccine Sales by Country (2018-2029)
3.4.3 North America Hepatitis A Vaccine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hepatitis A Vaccine Market Facts & Figures by Country
3.5.1 Europe Hepatitis A Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hepatitis A Vaccine Sales by Country (2018-2029)
3.5.3 Europe Hepatitis A Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis A Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatitis A Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hepatitis A Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Hepatitis A Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hepatitis A Vaccine Market Facts & Figures by Country
3.7.1 Latin America Hepatitis A Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hepatitis A Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Hepatitis A Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis A Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hepatitis A Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hepatitis A Vaccine Sales by Type (2018-2029)
4.1.1 Global Hepatitis A Vaccine Sales by Type (2018-2023)
4.1.2 Global Hepatitis A Vaccine Sales by Type (2024-2029)
4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Hepatitis A Vaccine Revenue by Type (2018-2029)
4.2.1 Global Hepatitis A Vaccine Revenue by Type (2018-2023)
4.2.2 Global Hepatitis A Vaccine Revenue by Type (2024-2029)
4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Hepatitis A Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Hepatitis A Vaccine Sales by Application (2018-2029)
5.1.1 Global Hepatitis A Vaccine Sales by Application (2018-2023)
5.1.2 Global Hepatitis A Vaccine Sales by Application (2024-2029)
5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Hepatitis A Vaccine Revenue by Application (2018-2029)
5.2.1 Global Hepatitis A Vaccine Revenue by Application (2018-2023)
5.2.2 Global Hepatitis A Vaccine Revenue by Application (2024-2029)
5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Hepatitis A Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Hepatitis A Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Hepatitis A Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sinovac
6.4.1 Sinovac Corporation Information
6.4.2 Sinovac Description and Business Overview
6.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
6.4.5 Sinovac Recent Developments/Updates
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Corporation Information
6.5.2 Zhejiang Pukang Description and Business Overview
6.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
6.5.5 Zhejiang Pukang Recent Developments/Updates
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
6.6.5 Changchun Institute of Biological Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 KM Biologics Hepatitis A Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 IMBCAMS
6.8.1 IMBCAMS Corporation Information
6.8.2 IMBCAMS Description and Business Overview
6.8.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 IMBCAMS Hepatitis A Vaccine Product Portfolio
6.8.5 IMBCAMS Recent Developments/Updates
6.9 Convac
6.9.1 Convac Corporation Information
6.9.2 Convac Description and Business Overview
6.9.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Convac Hepatitis A Vaccine Product Portfolio
6.9.5 Convac Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis A Vaccine Industry Chain Analysis
7.2 Hepatitis A Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis A Vaccine Production Mode & Process
7.4 Hepatitis A Vaccine Sales and Marketing
7.4.1 Hepatitis A Vaccine Sales Channels
7.4.2 Hepatitis A Vaccine Distributors
7.5 Hepatitis A Vaccine Customers
8 Hepatitis A Vaccine Market Dynamics
8.1 Hepatitis A Vaccine Industry Trends
8.2 Hepatitis A Vaccine Market Drivers
8.3 Hepatitis A Vaccine Market Challenges
8.4 Hepatitis A Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Hepatitis A Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Hepatitis A Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Hepatitis A Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Hepatitis A Vaccine Sales (K Unit) of Key Manufacturers (2018-2023)
Table 5. Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Hepatitis A Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Hepatitis A Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Hepatitis A Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Hepatitis A Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Hepatitis A Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis A Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis A Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis A Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Hepatitis A Vaccine Sales by Region (2018-2023) & (K Unit)
Table 18. Global Hepatitis A Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Hepatitis A Vaccine Sales by Region (2024-2029) & (K Unit)
Table 20. Global Hepatitis A Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Hepatitis A Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Hepatitis A Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Hepatitis A Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Hepatitis A Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Hepatitis A Vaccine Sales by Country (2018-2023) & (K Unit)
Table 27. North America Hepatitis A Vaccine Sales by Country (2024-2029) & (K Unit)
Table 28. North America Hepatitis A Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Hepatitis A Vaccine Sales by Country (2018-2023) & (K Unit)
Table 32. Europe Hepatitis A Vaccine Sales by Country (2024-2029) & (K Unit)
Table 33. Europe Hepatitis A Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Hepatitis A Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Hepatitis A Vaccine Sales by Region (2018-2023) & (K Unit)
Table 37. Asia Pacific Hepatitis A Vaccine Sales by Region (2024-2029) & (K Unit)
Table 38. Asia Pacific Hepatitis A Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Hepatitis A Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Hepatitis A Vaccine Sales by Country (2018-2023) & (K Unit)
Table 42. Latin America Hepatitis A Vaccine Sales by Country (2024-2029) & (K Unit)
Table 43. Latin America Hepatitis A Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hepatitis A Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Hepatitis A Vaccine Sales by Country (2018-2023) & (K Unit)
Table 47. Middle East & Africa Hepatitis A Vaccine Sales by Country (2024-2029) & (K Unit)
Table 48. Middle East & Africa Hepatitis A Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Hepatitis A Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Hepatitis A Vaccine Sales (K Unit) by Type (2018-2023)
Table 51. Global Hepatitis A Vaccine Sales (K Unit) by Type (2024-2029)
Table 52. Global Hepatitis A Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Hepatitis A Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Hepatitis A Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Hepatitis A Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Hepatitis A Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Hepatitis A Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Hepatitis A Vaccine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Hepatitis A Vaccine Price (USD/Unit) by Type (2024-2029)
Table 60. Global Hepatitis A Vaccine Sales (K Unit) by Application (2018-2023)
Table 61. Global Hepatitis A Vaccine Sales (K Unit) by Application (2024-2029)
Table 62. Global Hepatitis A Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Hepatitis A Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Hepatitis A Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Hepatitis A Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Hepatitis A Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Hepatitis A Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Hepatitis A Vaccine Price (USD/Unit) by Application (2018-2023)
Table 69. Global Hepatitis A Vaccine Price (USD/Unit) by Application (2024-2029)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. GSK Hepatitis A Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Merck Hepatitis A Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Hepatitis A Vaccine Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Sinovac Corporation Information
Table 86. Sinovac Description and Business Overview
Table 87. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Sinovac Hepatitis A Vaccine Product
Table 89. Sinovac Recent Developments/Updates
Table 90. Zhejiang Pukang Corporation Information
Table 91. Zhejiang Pukang Description and Business Overview
Table 92. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Zhejiang Pukang Hepatitis A Vaccine Product
Table 94. Zhejiang Pukang Recent Developments/Updates
Table 95. Changchun Institute of Biological Corporation Information
Table 96. Changchun Institute of Biological Description and Business Overview
Table 97. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Changchun Institute of Biological Hepatitis A Vaccine Product
Table 99. Changchun Institute of Biological Recent Developments/Updates
Table 100. KM Biologics Corporation Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. KM Biologics Hepatitis A Vaccine Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. IMBCAMS Corporation Information
Table 106. IMBCAMS Description and Business Overview
Table 107. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. IMBCAMS Hepatitis A Vaccine Product
Table 109. IMBCAMS Recent Developments/Updates
Table 110. Convac Corporation Information
Table 111. Convac Description and Business Overview
Table 112. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Convac Hepatitis A Vaccine Product
Table 114. Convac Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Hepatitis A Vaccine Distributors List
Table 118. Hepatitis A Vaccine Customers List
Table 119. Hepatitis A Vaccine Market Trends
Table 120. Hepatitis A Vaccine Market Drivers
Table 121. Hepatitis A Vaccine Market Challenges
Table 122. Hepatitis A Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis A Vaccine
Figure 2. Global Hepatitis A Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Hepatitis A Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Hepatitis A Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Hepatitis A Vaccine Market Share by Application in 2022 & 2029
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Global Hepatitis A Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Hepatitis A Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Hepatitis A Vaccine Sales (2018-2029) & (K Unit)
Figure 14. Global Hepatitis A Vaccine Average Price (USD/Unit) & (2018-2029)
Figure 15. Hepatitis A Vaccine Report Years Considered
Figure 16. Hepatitis A Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Hepatitis A Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Hepatitis A Vaccine Players: Market Share by Revenue in 2022
Figure 19. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Hepatitis A Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Hepatitis A Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America Hepatitis A Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Hepatitis A Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe Hepatitis A Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Hepatitis A Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Hepatitis A Vaccine Sales Market Share by Country (2018-2029)
Figure 45. Latin America Hepatitis A Vaccine Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Hepatitis A Vaccine Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Hepatitis A Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Hepatitis A Vaccine by Type (2018-2029)
Figure 55. Global Revenue Market Share of Hepatitis A Vaccine by Type (2018-2029)
Figure 56. Global Hepatitis A Vaccine Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Hepatitis A Vaccine by Application (2018-2029)
Figure 58. Global Revenue Market Share of Hepatitis A Vaccine by Application (2018-2029)
Figure 59. Global Hepatitis A Vaccine Price (USD/Unit) by Application (2018-2029)
Figure 60. Hepatitis A Vaccine Value Chain
Figure 61. Hepatitis A Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock